Condition: Coronary Artery Disease · Sponsor: Nanjing First Hospital, Nanjing Medical University
Drug-coated balloon (DCB) is an alternative choice for patients with coronary artery disease (CAD). This study is to investigate the efficacy and safety of DCB treatment in patients with CAD.
This description comes directly from the study's public registry record.
Jun-Jie Zhang, MD · 025-52271350 · jameszll@163.com
Xiao-Fei Gao, MD · 025-52271350 · gaoxiaofei2014@163.com
Always discuss trial participation with your own doctor first.
| Nanjing First Hospital | Nanjing, Jiangsu, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT04255563